Treasurer of the State of North Carolina reduced its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 19.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,617 shares of the company's stock after selling 6,538 shares during the quarter. Treasurer of the State of North Carolina's holdings in Molina Healthcare were worth $7,747,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in MOH. Wellington Management Group LLP boosted its stake in Molina Healthcare by 7.4% during the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after purchasing an additional 181,073 shares during the last quarter. FMR LLC lifted its holdings in shares of Molina Healthcare by 31.1% in the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after purchasing an additional 427,276 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Molina Healthcare by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after buying an additional 34,992 shares during the last quarter. Invesco Ltd. grew its holdings in Molina Healthcare by 28.5% during the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after buying an additional 294,180 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Molina Healthcare in the fourth quarter valued at about $134,675,000. 98.50% of the stock is owned by institutional investors.
Insiders Place Their Bets
In related news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now directly owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.26% of the company's stock.
Molina Healthcare Stock Down 3.0 %
Shares of Molina Healthcare stock traded down $9.81 during trading on Friday, hitting $322.57. The company's stock had a trading volume of 1,443,462 shares, compared to its average volume of 658,876. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $370.99. The company has a market capitalization of $17.64 billion, a PE ratio of 15.79, a P/E/G ratio of 1.06 and a beta of 0.70. The company has a fifty day simple moving average of $313.73 and a two-hundred day simple moving average of $308.23. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. Equities research analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Analyst Upgrades and Downgrades
MOH has been the subject of a number of research analyst reports. Guggenheim assumed coverage on Molina Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Truist Financial lifted their price objective on shares of Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research note on Friday, April 11th. StockNews.com upgraded Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, April 11th. Barclays lowered their price objective on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research report on Friday, February 7th. Finally, Robert W. Baird reiterated a "neutral" rating and set a $375.00 target price (up from $331.00) on shares of Molina Healthcare in a research report on Tuesday. Nine investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $359.42.
Get Our Latest Stock Report on MOH
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.